WallStSmart

Healthcare Triangle Inc (HCTI)vsHealthEquity Inc (HQY)

VS

Smart Verdict

WallStSmart Research — data-driven comparison

HealthEquity Inc generates 6572% more annual revenue ($1.34B vs $20.04M). HQY leads profitability with a 17.2% profit margin vs -69.7%. HCTI trades at a lower P/E of 0.0x. HQY earns a higher WallStSmart Score of 66/100 (B-).

HCTI

Hold

41

out of 100

Grade: D

Growth: 5.3Profit: 2.0Value: 6.7Quality: 4.5
Piotroski: 3/9Altman Z: -2.84

HQY

Strong Buy

66

out of 100

Grade: B-

Growth: 8.0Profit: 7.5Value: 6.7Quality: 8.0
Piotroski: 7/9Altman Z: 1.86
IV

Intrinsic Value Comparison

Multi-model valuation · Graham Formula

Intrinsic value data unavailable for HCTI.

HQYUndervalued (+49.0%)

Margin of Safety

+49.0%

Fair Value

$150.82

Current Price

$90.32

$60.50 discount

UndervaluedFair: $150.82Overvalued

Key Strengths & Concerns

Side-by-side fundamental analysis

Key Strengths

HCTI4 strengths · Avg: 9.8/10
P/E RatioValuation
0.0x10/10

Attractively priced relative to earnings

Price/BookValuation
0.1x10/10

Reasonable price relative to book value

Revenue GrowthGrowth
166.1%10/10

Revenue surging 166.1% year-over-year

Debt/EquityHealth
0.219/10

Conservative balance sheet, low leverage

HQY2 strengths · Avg: 8.0/10
Operating MarginProfitability
29.3%8/10

Strong operational efficiency at 29.3%

EPS GrowthGrowth
34.4%8/10

Earnings expanding 34.4% YoY

Areas to Watch

HCTI4 concerns · Avg: 3.0/10
EPS GrowthGrowth
0.0%4/10

0.0% earnings growth

Market CapQuality
$4.44M3/10

Smaller company, higher risk/reward

Piotroski F-ScoreQuality
3/93/10

Weak financial health signals

Return on EquityProfitability
-26.5%2/10

ROE of -26.5% — below average capital efficiency

HQY2 concerns · Avg: 4.0/10
P/E RatioValuation
31.8x4/10

Premium valuation, high expectations priced in

Altman Z-ScoreHealth
1.864/10

Grey zone — moderate risk

Comparative Analysis Report

WallStSmart Research

Bull Case : HCTI

The strongest argument for HCTI centers on P/E Ratio, Price/Book, Revenue Growth. Revenue growth of 166.1% demonstrates continued momentum.

Bull Case : HQY

The strongest argument for HQY centers on Operating Margin, EPS Growth. Profitability is solid with margins at 17.2% and operating margin at 29.3%. PEG of 1.22 suggests the stock is reasonably priced for its growth.

Bear Case : HCTI

The primary concerns for HCTI are EPS Growth, Market Cap, Piotroski F-Score.

Bear Case : HQY

The primary concerns for HQY are P/E Ratio, Altman Z-Score.

Key Dynamics to Monitor

HCTI profiles as a hypergrowth stock while HQY is a mature play — different risk/reward profiles.

HCTI carries more volatility with a beta of 1.05 — expect wider price swings.

HCTI is growing revenue faster at 166.1% — sustainability is the question.

HQY generates stronger free cash flow (97M), providing more financial flexibility.

Bottom Line

HQY scores higher overall (66/100 vs 41/100), backed by strong 17.2% margins. Both earn "Strong Buy" and "Hold" ratings respectively — the choice depends on your investment horizon and risk tolerance.

This analysis is generated from publicly available financial data. Not financial advice.

Healthcare Triangle Inc

HEALTHCARE · HEALTH INFORMATION SERVICES · USA

Healthcare Triangle, Inc. is a healthcare information technology company. The company is headquartered in Pleasanton, California.

HealthEquity Inc

HEALTHCARE · HEALTH INFORMATION SERVICES · USA

HealthEquity, Inc. provides technology-enabled service platforms to consumers and employers in the United States. The company is headquartered in Draper, Utah.

Want to dig deeper into these stocks?